Sigachi Industries Ltd
Sigachi Industries Ltd. (SIL) is one of the largest manufacturers of Microcrystalline Cellulose worldwide and has three Multi locational Facilities in Telangana and Gujarat.[1]
- Market Cap ₹ 1,601 Cr.
- Current Price ₹ 48.0
- High / Low ₹ 95.9 / 43.4
- Stock P/E 24.7
- Book Value ₹ 14.2
- Dividend Yield 0.21 %
- ROCE 16.7 %
- ROE 16.4 %
- Face Value ₹ 1.00
Pros
- Company is expected to give good quarter
- Company has delivered good profit growth of 24.6% CAGR over last 5 years
Cons
- Promoter holding has decreased over last quarter: -0.72%
- Company has a low return on equity of 12.8% over last 3 years.
- Company might be capitalizing the interest cost
- Debtor days have increased from 107 to 137 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Part of BSE Allcap BSE Healthcare BSE SmallCap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|
101 | 129 | 139 | 193 | 250 | 302 | 399 | 436 | |
89 | 103 | 114 | 154 | 197 | 243 | 322 | 359 | |
Operating Profit | 12 | 26 | 25 | 39 | 53 | 59 | 77 | 77 |
OPM % | 12% | 20% | 18% | 20% | 21% | 19% | 19% | 18% |
3 | 4 | 5 | 3 | 3 | 7 | 12 | 25 | |
Interest | 4 | 3 | 2 | 1 | 1 | 4 | 8 | 10 |
Depreciation | 1 | 2 | 2 | 2 | 3 | 7 | 11 | 13 |
Profit before tax | 10 | 25 | 25 | 38 | 52 | 54 | 70 | 80 |
Tax % | 28% | 23% | 20% | 21% | 22% | 20% | 18% | |
7 | 19 | 20 | 30 | 40 | 44 | 57 | 65 | |
EPS in Rs | 2.25 | 6.19 | 2.65 | 3.94 | 1.30 | 0.00 | 1.74 | 2.01 |
Dividend Payout % | 4% | 2% | 4% | 0% | 8% | 6% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 25% |
3 Years: | 27% |
TTM: | 34% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 25% |
3 Years: | 24% |
TTM: | 50% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -2% |
1 Year: | -13% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 17% |
3 Years: | 13% |
Last Year: | 16% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|
Equity Capital | 3 | 3 | 8 | 8 | 31 | 31 | 33 | 33 |
Reserves | 23 | 42 | 57 | 87 | 197 | 238 | 397 | 438 |
30 | 25 | 30 | 21 | 35 | 68 | 151 | 137 | |
16 | 21 | 14 | 18 | 24 | 37 | 113 | 144 | |
Total Liabilities | 72 | 91 | 109 | 133 | 287 | 374 | 694 | 753 |
26 | 29 | 32 | 38 | 53 | 122 | 254 | 361 | |
CWIP | 1 | 2 | 3 | 4 | 10 | 35 | 97 | 8 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
46 | 61 | 74 | 92 | 224 | 216 | 342 | 384 | |
Total Assets | 72 | 91 | 109 | 133 | 287 | 374 | 694 | 753 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|
8 | 14 | 12 | 30 | 6 | 29 | 13 | |
-4 | -6 | -7 | -11 | -63 | -92 | -161 | |
-5 | -9 | 3 | -11 | 108 | 26 | 172 | |
Net Cash Flow | -1 | -0 | 8 | 7 | 51 | -37 | 24 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|
Debtor Days | 77 | 70 | 72 | 68 | 88 | 97 | 137 |
Inventory Days | 99 | 123 | 141 | 77 | 94 | 123 | 132 |
Days Payable | 52 | 48 | 37 | 29 | 33 | 55 | 90 |
Cash Conversion Cycle | 124 | 145 | 177 | 116 | 149 | 165 | 180 |
Working Capital Days | 97 | 105 | 130 | 105 | 134 | 137 | 150 |
ROCE % | 44% | 34% | 38% | 28% | 20% | 17% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
19 Nov - Transcript of Earnings call held on November 13,2024.
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
14 Nov - Submission of Monitoring Agency Report for IPO proceeds.
-
Statement Of Deviation / Variation In Utilization Of Funds Raised In IPO / Conversion Of Share Warrants Into Equity Shares
14 Nov - Statement of deviation in IPO fund utilization.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
14 Nov - Newspaper publications of Unaudited Financial Results (Standalone & Consolidated) for quarter and half year ended 30.09.2024
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
13 Nov - Audio recording of Q2 FY 2024-25 earnings call available.
Annual reports
Concalls
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
Jun 2024Transcript PPT REC
-
Jan 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Nov 2023TranscriptPPT
-
Aug 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
May 2023TranscriptNotesPPT REC
-
Feb 2023TranscriptPPT
-
Feb 2023Transcript PPT
-
Jan 2023TranscriptNotesPPT
-
Dec 2022TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
Jul 2022Transcript PPT
-
May 2022Transcript PPT
Business Segments Q1 FY25